Cargando…
Bovine Herpesvirus Type 4 (BoHV-4) Vector Delivering Nucleocapsid Protein of Crimean-Congo Hemorrhagic Fever Virus Induces Comparable Protective Immunity against Lethal Challenge in IFNα/β/γR−/− Mice Models
Crimean-Congo hemorrhagic fever virus (CCHFV) is the causative agent of a tick-borne infection with a significant mortality rate of up to 40% in endemic areas, with evidence of geographical expansion. Due to a lack of effective therapeutics and control measures, the development of a protective CCHFV...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6466008/ https://www.ncbi.nlm.nih.gov/pubmed/30857305 http://dx.doi.org/10.3390/v11030237 |
_version_ | 1783411011045294080 |
---|---|
author | Aligholipour Farzani, Touraj Földes, Katalin Hanifehnezhad, Alireza Yener Ilce, Burcu Bilge Dagalp, Seval Amirzadeh Khiabani, Neda Ergünay, Koray Alkan, Feray Karaoglu, Taner Bodur, Hurrem Ozkul, Aykut |
author_facet | Aligholipour Farzani, Touraj Földes, Katalin Hanifehnezhad, Alireza Yener Ilce, Burcu Bilge Dagalp, Seval Amirzadeh Khiabani, Neda Ergünay, Koray Alkan, Feray Karaoglu, Taner Bodur, Hurrem Ozkul, Aykut |
author_sort | Aligholipour Farzani, Touraj |
collection | PubMed |
description | Crimean-Congo hemorrhagic fever virus (CCHFV) is the causative agent of a tick-borne infection with a significant mortality rate of up to 40% in endemic areas, with evidence of geographical expansion. Due to a lack of effective therapeutics and control measures, the development of a protective CCHFV vaccine remains a crucial public health task. This paper describes, for the first time, a Bovine herpesvirus type 4 (BoHV-4)-based viral vector (BoHV4-∆TK-CCHFV-N) and its immunogenicity in BALB/c and protection potential in IFNα/β/γR−/− mice models in comparison with two routinely used vaccine platforms, namely, Adenovirus type 5 and a DNA vector (pCDNA3.1 myc/His A), expressing the same antigen. All vaccine constructs successfully elicited significantly elevated cytokine levels and specific antibody responses in immunized BALB/c and IFNα/β/γR−/− mice. However, despite highly specific antibody responses in both animal models, the antibodies produced were unable to neutralize the virus in vitro. In the challenge experiment, only the BoHV4-∆TK-CCHFV-N and Ad5-N constructs produced 100% protection against lethal doses of the CCHFV Ank-2 strain in IFNα/β/γR−/− mice. The delivery platforms could not be compared due to similar protection rates in IFNα/β/γR−/− mice. However, during the challenge experiment in the T cell and passive antibody transfer assay, BoHV4-∆TK-CCHFV-N was dominant, with a protection rate of 75% compared to others. In conclusion, vector-based CCHFV N protein expression constitutes an effective approach for vaccine development and BoHV-4 emerged as a strong alternative to previously used viral vectors. |
format | Online Article Text |
id | pubmed-6466008 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-64660082019-04-18 Bovine Herpesvirus Type 4 (BoHV-4) Vector Delivering Nucleocapsid Protein of Crimean-Congo Hemorrhagic Fever Virus Induces Comparable Protective Immunity against Lethal Challenge in IFNα/β/γR−/− Mice Models Aligholipour Farzani, Touraj Földes, Katalin Hanifehnezhad, Alireza Yener Ilce, Burcu Bilge Dagalp, Seval Amirzadeh Khiabani, Neda Ergünay, Koray Alkan, Feray Karaoglu, Taner Bodur, Hurrem Ozkul, Aykut Viruses Article Crimean-Congo hemorrhagic fever virus (CCHFV) is the causative agent of a tick-borne infection with a significant mortality rate of up to 40% in endemic areas, with evidence of geographical expansion. Due to a lack of effective therapeutics and control measures, the development of a protective CCHFV vaccine remains a crucial public health task. This paper describes, for the first time, a Bovine herpesvirus type 4 (BoHV-4)-based viral vector (BoHV4-∆TK-CCHFV-N) and its immunogenicity in BALB/c and protection potential in IFNα/β/γR−/− mice models in comparison with two routinely used vaccine platforms, namely, Adenovirus type 5 and a DNA vector (pCDNA3.1 myc/His A), expressing the same antigen. All vaccine constructs successfully elicited significantly elevated cytokine levels and specific antibody responses in immunized BALB/c and IFNα/β/γR−/− mice. However, despite highly specific antibody responses in both animal models, the antibodies produced were unable to neutralize the virus in vitro. In the challenge experiment, only the BoHV4-∆TK-CCHFV-N and Ad5-N constructs produced 100% protection against lethal doses of the CCHFV Ank-2 strain in IFNα/β/γR−/− mice. The delivery platforms could not be compared due to similar protection rates in IFNα/β/γR−/− mice. However, during the challenge experiment in the T cell and passive antibody transfer assay, BoHV4-∆TK-CCHFV-N was dominant, with a protection rate of 75% compared to others. In conclusion, vector-based CCHFV N protein expression constitutes an effective approach for vaccine development and BoHV-4 emerged as a strong alternative to previously used viral vectors. MDPI 2019-03-09 /pmc/articles/PMC6466008/ /pubmed/30857305 http://dx.doi.org/10.3390/v11030237 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Aligholipour Farzani, Touraj Földes, Katalin Hanifehnezhad, Alireza Yener Ilce, Burcu Bilge Dagalp, Seval Amirzadeh Khiabani, Neda Ergünay, Koray Alkan, Feray Karaoglu, Taner Bodur, Hurrem Ozkul, Aykut Bovine Herpesvirus Type 4 (BoHV-4) Vector Delivering Nucleocapsid Protein of Crimean-Congo Hemorrhagic Fever Virus Induces Comparable Protective Immunity against Lethal Challenge in IFNα/β/γR−/− Mice Models |
title | Bovine Herpesvirus Type 4 (BoHV-4) Vector Delivering Nucleocapsid Protein of Crimean-Congo Hemorrhagic Fever Virus Induces Comparable Protective Immunity against Lethal Challenge in IFNα/β/γR−/− Mice Models |
title_full | Bovine Herpesvirus Type 4 (BoHV-4) Vector Delivering Nucleocapsid Protein of Crimean-Congo Hemorrhagic Fever Virus Induces Comparable Protective Immunity against Lethal Challenge in IFNα/β/γR−/− Mice Models |
title_fullStr | Bovine Herpesvirus Type 4 (BoHV-4) Vector Delivering Nucleocapsid Protein of Crimean-Congo Hemorrhagic Fever Virus Induces Comparable Protective Immunity against Lethal Challenge in IFNα/β/γR−/− Mice Models |
title_full_unstemmed | Bovine Herpesvirus Type 4 (BoHV-4) Vector Delivering Nucleocapsid Protein of Crimean-Congo Hemorrhagic Fever Virus Induces Comparable Protective Immunity against Lethal Challenge in IFNα/β/γR−/− Mice Models |
title_short | Bovine Herpesvirus Type 4 (BoHV-4) Vector Delivering Nucleocapsid Protein of Crimean-Congo Hemorrhagic Fever Virus Induces Comparable Protective Immunity against Lethal Challenge in IFNα/β/γR−/− Mice Models |
title_sort | bovine herpesvirus type 4 (bohv-4) vector delivering nucleocapsid protein of crimean-congo hemorrhagic fever virus induces comparable protective immunity against lethal challenge in ifnα/β/γr−/− mice models |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6466008/ https://www.ncbi.nlm.nih.gov/pubmed/30857305 http://dx.doi.org/10.3390/v11030237 |
work_keys_str_mv | AT aligholipourfarzanitouraj bovineherpesvirustype4bohv4vectordeliveringnucleocapsidproteinofcrimeancongohemorrhagicfevervirusinducescomparableprotectiveimmunityagainstlethalchallengeinifnabgrmicemodels AT foldeskatalin bovineherpesvirustype4bohv4vectordeliveringnucleocapsidproteinofcrimeancongohemorrhagicfevervirusinducescomparableprotectiveimmunityagainstlethalchallengeinifnabgrmicemodels AT hanifehnezhadalireza bovineherpesvirustype4bohv4vectordeliveringnucleocapsidproteinofcrimeancongohemorrhagicfevervirusinducescomparableprotectiveimmunityagainstlethalchallengeinifnabgrmicemodels AT yenerilceburcu bovineherpesvirustype4bohv4vectordeliveringnucleocapsidproteinofcrimeancongohemorrhagicfevervirusinducescomparableprotectiveimmunityagainstlethalchallengeinifnabgrmicemodels AT bilgedagalpseval bovineherpesvirustype4bohv4vectordeliveringnucleocapsidproteinofcrimeancongohemorrhagicfevervirusinducescomparableprotectiveimmunityagainstlethalchallengeinifnabgrmicemodels AT amirzadehkhiabanineda bovineherpesvirustype4bohv4vectordeliveringnucleocapsidproteinofcrimeancongohemorrhagicfevervirusinducescomparableprotectiveimmunityagainstlethalchallengeinifnabgrmicemodels AT ergunaykoray bovineherpesvirustype4bohv4vectordeliveringnucleocapsidproteinofcrimeancongohemorrhagicfevervirusinducescomparableprotectiveimmunityagainstlethalchallengeinifnabgrmicemodels AT alkanferay bovineherpesvirustype4bohv4vectordeliveringnucleocapsidproteinofcrimeancongohemorrhagicfevervirusinducescomparableprotectiveimmunityagainstlethalchallengeinifnabgrmicemodels AT karaoglutaner bovineherpesvirustype4bohv4vectordeliveringnucleocapsidproteinofcrimeancongohemorrhagicfevervirusinducescomparableprotectiveimmunityagainstlethalchallengeinifnabgrmicemodels AT bodurhurrem bovineherpesvirustype4bohv4vectordeliveringnucleocapsidproteinofcrimeancongohemorrhagicfevervirusinducescomparableprotectiveimmunityagainstlethalchallengeinifnabgrmicemodels AT ozkulaykut bovineherpesvirustype4bohv4vectordeliveringnucleocapsidproteinofcrimeancongohemorrhagicfevervirusinducescomparableprotectiveimmunityagainstlethalchallengeinifnabgrmicemodels |